| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| SEVIKAR HCT 40mg/5 mg/25 mg | COMBINATII (OLMESARTANUM+AMLODIPINUM+HCT) | COMPR. FILM. | C09DX03 | W68196013 | LABORMED PHARMA S.A. - ROMANIA | ||||||
| SEVIKAR HCT 40mg/5 mg/25 mg | COMBINATII (OLMESARTANUM+AMLODIPINUM+HCT) | COMPR. FILM. | C09DX03 | W68196014 | LABORMED PHARMA S.A. - ROMANIA | ||||||
| SEVIKAR HCT 40mg/5 mg/25 mg | COMBINATII (OLMESARTANUM+AMLODIPINUM+HCT) | COMPR. FILM. | C09DX03 | W68196015 | LABORMED PHARMA S.A. - ROMANIA | ||||||
| SEVO-ANESTERAN | SEVOFLURANUM | VAPORI DE INHALAT, LICHID | N01AB08 | W62917001 | ROMPHARM COMPANY S.R.L. - ROMANIA | ||||||
| SEVO-ANESTERAN | SEVOFLURANUM | VAPORI DE INHALAT, LICHID | N01AB08 | W62917002 | ROMPHARM COMPANY S.R.L. - ROMANIA | ||||||
| SEVOFLURAN BAXTER 100% | SEVOFLURANUM | LICHID PT. VAPORI DE INHAL. | N01AB08 | W55827001 | BAXTER SA - BELGIA | ||||||
| SEVOFLURAN BAXTER 100% | SEVOFLURANUM | LICHID PT. VAPORI DE INHAL. | N01AB08 | W55827002 | BAXTER SA - BELGIA | ||||||
| SEVREDOL 10 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59252001 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 10 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59252002 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 10 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59252003 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 20 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59251001 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 20 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59251002 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SEVREDOL 20 mg | MORPHYNUM | COMPR. FILM. | N02AA01 | W59251003 | MUNDIPHARMA GES.M.B.H. - AUSTRIA | ||||||
| SIALANAR 320 micrograme/ml | GLICOPIRONIUM BROMIDUM | SOL. ORALA | A03AB02 | W69128001 | PROVECA PHARMA LIMITED - IRLANDA | X | |||||
| SIALANAR 320 micrograme/ml | GLICOPIRONIUM BROMIDUM | SOL. ORALA | A03AB02 | W69128002 | PROVECA PHARMA LIMITED - IRLANDA | X | |||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202001 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202002 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202003 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202004 | EGIS PHARMACEUTICALS PLC. - UNGARIA | ||||||
| SIANTA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70202005 | EGIS PHARMACEUTICALS PLC. - UNGARIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman